Literature DB >> 19604309

Signal transducer and activator of transcription 4 limits the development of adaptive regulatory T cells.

John T O'Malley1, Sarita Sehra, Vivian T Thieu, Qing Yu, Hua-Chen Chang, Gretta L Stritesky, Evelyn T Nguyen, Anubhav N Mathur, David E Levy, Mark H Kaplan.   

Abstract

T-cell responses to a cytokine milieu instruct the development of multiple effector phenotypes. While transforming growth factor-beta(1) (TGF-beta(1)) inhibits the development of T helper type 1 (Th1) and Th2 cells, we demonstrate that like interleukin-6 (IL-6) and IL-4, IL-12 can inhibit the development of TGF-beta(1)-induced Foxp3-expressing adaptive T regulatory (aTreg) cells. Signal transducer and activator of transcription 4 (STAT4) is critical for the response to IL-12, although there is a parallel pathway involving T box expressed in T cells (T-bet), and cells from mice double-deficient in STAT4 and T-bet are refractory to the inhibition of aTreg-cell development by IL-12. While the ability of these cytokines to promote Th differentiation may contribute to this effect, we observe that culture with IL-12, or other instructive cytokines, results in an increase in repressive chromatin modifications at the Foxp3 locus that limit STAT5 binding to Foxp3, without observed effects on IL-2 signalling pathways. In a model of allergic lung inflammation there are increased percentages of Treg cells in the lungs of Stat4(-/-) mice, compared with wild-type mice, and increases in Treg cells correlate with decreased allergic inflammation. Overall, these results suggest an important role for STAT4 in regulating Treg-cell development.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19604309      PMCID: PMC2729536          DOI: 10.1111/j.1365-2567.2008.03037.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  44 in total

1.  Cutting edge: changes in histone acetylation at the IL-4 and IFN-gamma loci accompany Th1/Th2 differentiation.

Authors:  Patrick E Fields; Sean T Kim; Richard A Flavell
Journal:  J Immunol       Date:  2002-07-15       Impact factor: 5.422

2.  Dynamic changes in histone H3 Lys 9 methylation occurring at tightly regulated inducible inflammatory genes.

Authors:  Simona Saccani; Gioacchino Natoli
Journal:  Genes Dev       Date:  2002-09-01       Impact factor: 11.361

3.  T-bet is rapidly induced by interferon-gamma in lymphoid and myeloid cells.

Authors:  A A Lighvani; D M Frucht; D Jankovic; H Yamane; J Aliberti; B D Hissong; B V Nguyen; M Gadina; A Sher; W E Paul; J J O'Shea
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-18       Impact factor: 11.205

Review 4.  TGF-beta1: immunosuppressant and viability factor for T lymphocytes.

Authors:  A Cerwenka; S L Swain
Journal:  Microbes Infect       Date:  1999-12       Impact factor: 2.700

5.  T-bet is a STAT1-induced regulator of IL-12R expression in naïve CD4+ T cells.

Authors:  Maryam Afkarian; John R Sedy; Jianfei Yang; Nils G Jacobson; Nezih Cereb; Soo Y Yang; Theresa L Murphy; Kenneth M Murphy
Journal:  Nat Immunol       Date:  2002-05-13       Impact factor: 25.606

6.  Role of T-bet in commitment of TH1 cells before IL-12-dependent selection.

Authors:  A C Mullen; F A High; A S Hutchins; H W Lee; A V Villarino; D M Livingston; A L Kung; N Cereb; T P Yao; S Y Yang; S L Reiner
Journal:  Science       Date:  2001-06-08       Impact factor: 47.728

7.  Distinct effects of T-bet in TH1 lineage commitment and IFN-gamma production in CD4 and CD8 T cells.

Authors:  Susanne J Szabo; Brandon M Sullivan; Claudia Stemmann; Abhay R Satoskar; Barry P Sleckman; Laurie H Glimcher
Journal:  Science       Date:  2002-01-11       Impact factor: 47.728

8.  STAT4 signal pathways regulate inflammation and airway physiology changes in allergic airway inflammation locally via alteration of chemokines.

Authors:  Kavita Raman; Mark H Kaplan; Cory M Hogaboam; Aaron Berlin; Nicholas W Lukacs
Journal:  J Immunol       Date:  2003-04-01       Impact factor: 5.422

9.  Distinct requirements for the naturally occurring splice forms Stat4alpha and Stat4beta in IL-12 responses.

Authors:  Timothy Hoey; Shangming Zhang; Nathan Schmidt; Qing Yu; Shyam Ramchandani; Xiang Xu; Lisa K Naeger; Ya-Lin Sun; Mark H Kaplan
Journal:  EMBO J       Date:  2003-08-15       Impact factor: 11.598

10.  IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates IL-9+ IL-10+ Foxp3(-) effector T cells.

Authors:  Valérie Dardalhon; Amit Awasthi; Hyoung Kwon; George Galileos; Wenda Gao; Raymond A Sobel; Meike Mitsdoerffer; Terry B Strom; Wassim Elyaman; I-Cheng Ho; Samia Khoury; Mohamed Oukka; Vijay K Kuchroo
Journal:  Nat Immunol       Date:  2008-11-09       Impact factor: 25.606

View more
  28 in total

Review 1.  Regulation of CD4+ T-cell polarization by suppressor of cytokine signalling proteins.

Authors:  Camille A Knosp; James A Johnston
Journal:  Immunology       Date:  2012-02       Impact factor: 7.397

Review 2.  Functions of thymic stromal lymphopoietin in immunity and disease.

Authors:  Yanlu Zhang; Baohua Zhou
Journal:  Immunol Res       Date:  2012-06       Impact factor: 2.829

3.  Androgens alter T-cell immunity by inhibiting T-helper 1 differentiation.

Authors:  Haydn T Kissick; Martin G Sanda; Laura K Dunn; Kathryn L Pellegrini; Seung T On; Jonathan K Noel; Mohamed S Arredouani
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-23       Impact factor: 11.205

4.  Changing the STATus quo in T helper cells.

Authors:  Gretta L Stritesky; Mark H Kaplan
Journal:  Transcription       Date:  2011-07

Review 5.  The symphony of the ninth: the development and function of Th9 cells.

Authors:  Rukhsana Jabeen; Mark H Kaplan
Journal:  Curr Opin Immunol       Date:  2012-02-22       Impact factor: 7.486

6.  STAT6-dependent regulation of Th9 development.

Authors:  Ritobrata Goswami; Rukhsana Jabeen; Ryoji Yagi; Duy Pham; Jinfang Zhu; Shreevrat Goenka; Mark H Kaplan
Journal:  J Immunol       Date:  2011-12-16       Impact factor: 5.422

7.  Dab2, a negative regulator of DC immunogenicity, is an attractive molecular target for DC-based immunotherapy.

Authors:  Md Selim Ahmed; Se Eun Byeon; Yideul Jeong; Mohammad Alam Miah; Md Salahuddin; Yoon Lee; Sung-Soo Park; Yong-Soo Bae
Journal:  Oncoimmunology       Date:  2015-02-03       Impact factor: 8.110

Review 8.  Rapamycin-resistant effector T-cell therapy.

Authors:  Daniel H Fowler
Journal:  Immunol Rev       Date:  2014-01       Impact factor: 12.988

9.  STAT4 deficiency reduces the development of atherosclerosis in mice.

Authors:  Parésa L Taghavie-Moghadam; Breanne N Gjurich; Rukhsana Jabeen; Purna Krishnamurthy; Mark H Kaplan; Anca D Dobrian; Jerry L Nadler; Elena V Galkina
Journal:  Atherosclerosis       Date:  2015-09-04       Impact factor: 5.162

10.  Opposing roles of STAT4 and Dnmt3a in Th1 gene regulation.

Authors:  Duy Pham; Qing Yu; Crystal C Walline; Rajarajeswari Muthukrishnan; Janice S Blum; Mark H Kaplan
Journal:  J Immunol       Date:  2013-06-14       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.